Trials / Completed
CompletedNCT03904199
Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia
A Prospective Randomized Study of a Personalized Approach to the Inpatient Management of Hospitalized Oncology Patients With Hyperglycemia
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the outcomes between hospitalized cancer patients with high blood sugar receiving the current standard of care of administering insulin, and hospitalized cancer patients receiving a new, individualized method of insulin administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin | Participants will receive long-acting insulin and/or rapid-acting insulin per protocol |
Timeline
- Start date
- 2019-04-04
- Primary completion
- 2020-10-14
- Completion
- 2021-11-02
- First posted
- 2019-04-05
- Last updated
- 2023-01-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03904199. Inclusion in this directory is not an endorsement.